Amgen’s Prolia Boxed Warning On Hypocalcemia Risk Backed By Medicare Data

 
• By Sue Sutter
  
Calcium test
A new boxed warning on Prolia labeling focuses on the risk of hypocalcemia in patients with kidney disease. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Drug Safety

More from Pink Sheet